Selfdiagnostics

Selfdiagnostics is an Estonian-German diagnostics company developing and commercializing point-of-care and self-use medical diagnostic devices, with a particular focus on rapid molecular testing. Its core offering is the Selfdiagnostics Multitest platform, a disposable PCR-grade or NAAT-based testing platform designed to deliver near-laboratory accuracy without the need for complex instrumentation. The company has highlighted products and programs for sexually transmitted infection testing, including Chlamydia trachomatis and Neisseria gonorrhoeae, as well as COVID-19 and influenza testing. In addition to molecular tests, Selfdiagnostics has marketed rapid antigen and antibody tests and related home-use diagnostics. The business appears to operate as a private medtech/diagnostics company with activities spanning development, manufacturing, distribution, and commercialization in Europe.